Creating a Vaccine to Guide the Immune System to Make the Right Kind of Antibodies

Researchers at the Duke Human Vaccine Institute are leaders in research aimed at developing vaccines that teach the human immune system to respond to diseases like influenza, HIV, and cytomegalovirus (CMV) which impact hundreds of thousands of people globally. The Immune Resiliency Initiative, which is part of Duke’s larger Science and Technology endeavor, encompasses this work.

Duke Human Vaccine Institute is part of the Duke University School of Medicine and Duke Health.